comparemela.com

Latest Breaking News On - Supernus pharmaceuticals - Page 1 : comparemela.com

Scout Investments Inc. Lowers Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

Scout Investments Inc. lowered its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 282,400 shares of the specialty pharmaceutical company’s stock after selling 4,429 shares during the period. Scout Investments Inc. owned approximately […]

New-jersey
United-states
Switzerland
Swiss
Padmanabhp-bhatt
Piper-sandler
Quarter-for-supernus-pharmaceuticals
Securities-exchange-commission
Scout-investments-inc
Supernus-pharmaceuticals-company-profile
Deutsche-bank
Supernus-pharmaceuticals-inc

Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Rockville
Timothyc-dec
Peter-vozzo
Jacka-khattar
Jack-khattar
Supernus-pharmaceuticals
Nasdaq
Exchange-commission
Marriott-marquis-hotel
Securities-exchange

Supernus Pharmaceuticals to Participate in the Jefferies

Supernus Pharmaceuticals to Participate in the Jefferies
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Rockville
Timothyc-dec
Jacka-khattar
Peter-vozzo
Jack-khattar
Securities-exchange
Supernus-pharmaceuticals-inc
Marriott-marquis-hotel
Exchange-commission
Nasdaq

Congress Wealth Management LLC DE Cuts Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

Congress Wealth Management LLC DE trimmed its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 18.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 129,051 shares of the specialty pharmaceutical company’s stock after selling 30,095 shares during the quarter. Congress […]

United-states
Padmanabhp-bhatt
Piper-sandler
Dimensional-fund-advisors
Securities-exchange-commission
Supernus-pharmaceuticals-company-profile
Quarter-for-supernus-pharmaceuticals
Loomis-sayles-co
Armistice-capital
Exchange-commission
Nasdaq
Norges-bank

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc.

/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN)..

New-york
United-states
Tel-aviv
Israel
Chicago
Illinois
Paris
France-general
France
London
City-of
United-kingdom

vimarsana © 2020. All Rights Reserved.